PRESTRELSKI STEVEN (Chief Scientific Officer) reported 1 transaction at XERIS PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 12/17/2020ACC: 0001346302-20-000083
Officer· Chief Scientific Officer
Since Dec 2018
-10K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
10K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10K
Price / share
—
Trade value
—
% of position
2.3%
12/16/2020
436.82K→426.82K
Total
Net shares
−10K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/16/2020 | G · Gift | −10K | — | — | 2.3% | 436.82K | 426.82K |
| Total | −10K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported